Literature DB >> 14676975

Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound.

Masahiko Koda1, Yoshiko Matsunaga, Masaru Ueki, Yoshiko Maeda, Ken-ichi Mimura, Kinya Okamoto, Keiko Hosho, Yoshikazu Murawaki.   

Abstract

The purpose of this study was to evaluate the detection rate of tumor vessels and vascularity in hepatocellular carcinoma (HCC) by contrast-enhanced coded US using Levovist, and to compare with conventional color/power Doppler US (CDUS) and dynamic CT. Ninety nodules (72 hypo/isoechoic nodules, 18 hyperechoic nodules) in 61 patients were studied. We observed tumor vessels by continuous transmission at the early vascular phase (40 s following administration of Levovist) and vascularity by intermittent transmission (intervals of 2-3 s) at the late vascular phase (40 to approximately 120 s). The detection rate of tumor vessels at the early vascular phase was 97% in hypo/isoechoic nodules and 70% in hyperechoic nodules with high density in dynamic CT being higher than that by CDUS. Tumor vascularity at the late vascular phase in hypo/isoechoic and hyperechoic nodules was hyper-enhancement in 78 and 40%, iso-enhancement in 19 and 40%, and hypo-enhancement in 3 and 0%, respectively. The detection rates of tumor vessels and vascularity in hyperechoic nodules were similar to those by CDUS. The detection rates of tumor vessels and vascularity were not affected by the tumor size in HCC tumors with high density in dynamic CT. Contrast-enhanced US with Levovist was superior to CDUS and equal to dynamic CT to assess tumor vessels in hypo/isoechoic nodules. Although it was equal to CDUS for hyperechoic nodules, this modality is useful in evaluating tumor hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14676975     DOI: 10.1007/s00330-003-2172-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.

Authors:  H Ding; M Kudo; H Onda; Y Suetomi; Y Minami; H Chung; T Kawasaki; K Maekawa
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

Review 2.  The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions.

Authors:  E Leen
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

3.  Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.

Authors:  A L Fracanzani; L Burdick; M Borzio; M Roncalli; N Bonelli; F Borzio; A Maraschi; G Fiorelli; S Fargion
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

4.  Ultrasound imaging of focal liver lesions with a second-generation contrast agent.

Authors:  Riccardo Lencioni; Dania Cioni; Laura Crocetti; Francescamaria Donati; Chiara Franchini; Sabina Giusti; Carlo Bartolozzi
Journal:  Acad Radiol       Date:  2002-08       Impact factor: 3.173

5.  Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode.

Authors:  H Ding; M Kudo; H Onda; Y Suetomi; Y Minami; K Maekawa
Journal:  Radiology       Date:  2001-08       Impact factor: 11.105

6.  Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.

Authors:  M Hayashi; O Matsui; K Ueda; Y Kawamori; M Kadoya; J Yoshikawa; T Gabata; T Takashima; A Nonomura; Y Nakanuma
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

Review 7.  Ultrasound of focal liver lesions.

Authors:  C J Harvey; T Albrecht
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

8.  Characterization of liver hemangiomas with pulse inversion harmonic imaging.

Authors:  Emilio Quaia; Michele Bertolotto; Ludovico Dalla Palma
Journal:  Eur Radiol       Date:  2001-11-10       Impact factor: 5.315

9.  Early hepatocellular carcinoma: appearance at CT during arterial portography and CT arteriography with pathologic correlation.

Authors:  K Takayasu; Y Muramatsu; H Furukawa; F Wakao; N Moriyama; T Takayama; S Yamasaki; M Sakamoto; S Hirohashi
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

10.  Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.

Authors:  A Y Kim; B I Choi; T K Kim; J K Han; E J Yun; K Y Lee; M C Han
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

View more
  11 in total

Review 1.  Contrast-enhanced and targeted ultrasound.

Authors:  Michiel Postema; Odd Helge Gilja
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

2.  Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging.

Authors:  Katsutoshi Sugimoto; Fuminori Moriyasu; Junji Shiraishi; Kazuhiro Saito; Junichi Taira; Toru Saguchi; Yasuharu Imai
Journal:  Eur Radiol       Date:  2012-01-24       Impact factor: 5.315

3.  Contrast-enhanced computed tomography and ultrasound for the evaluation of tumor blood flow.

Authors:  Amy R Broumas; Rachel E Pollard; Susannah H Bloch; Erik R Wisner; Stephen Griffey; Katherine W Ferrara
Journal:  Invest Radiol       Date:  2005-03       Impact factor: 6.016

4.  Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.

Authors:  Xiao-Yun Zhang; Yan Luo; Tian-Fu Wen; Li Jiang; Chuan Li; Xiao-Fei Zhong; Jing-Yi Zhang; Wen-Wu Ling; Lu-Nan Yan; Yong Zeng; Hong Wu
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

5.  Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound--initial results.

Authors:  M Krix; C Plathow; M Essig; K Herfarth; J Debus; H-U Kauczor; S Delorme
Journal:  Eur Radiol       Date:  2005-02-24       Impact factor: 5.315

6.  Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model.

Authors:  A Maataoui; J Qian; D Vossoughi; M F Khan; E Oppermann; W O Bechstein; T J Vogl
Journal:  Eur Radiol       Date:  2004-12-04       Impact factor: 5.315

7.  MR diffusion-weighed imaging of rabbit liver.

Authors:  You-Hong Yuan; En-Hua Xiao; Zhong He; Jun Xiang; Ke-Li Tang; Rong-Hua Yan; Ke Jin; Zi-Wen Peng
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

8.  Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.

Authors:  M Mandai; M Koda; T Matono; T Nagahara; T Sugihara; M Ueki; K Ohyama; Y Murawaki
Journal:  Br J Radiol       Date:  2010-10-19       Impact factor: 3.039

9.  Cracking pattern of tissue slices induced by external extension provides useful diagnostic information.

Authors:  Keisuke Danno; Takuto Nakamura; Natsumi Okoso; Naohiko Nakamura; Kohta Iguchi; Yoshiaki Iwadate; Takahiro Kenmotsu; Masaya Ikegawa; Shinji Uemoto; Kenichi Yoshikawa
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

10.  Contrast-Enhanced Ultrasound in Residual Tumor of Hepatocellular Carcinoma following Transarterial Chemoembolization: Is It Helpful for Tumor Response?

Authors:  Tian'an Jiang; Qiyu Zhao; Min Huang; Junhui Sun; Guo Tian
Journal:  Biomed Res Int       Date:  2018-08-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.